022 - "What Chapter are you in?" with Susan Neadle

Let's Combinate · 2 Mar 2022 · 1h 23m

What this episode covers

Susan Neadle, Principal Consultant at Combination Products Consulting Services LLC and former Head of Combination Products at Amgen and Johnson & Johnson, discusses the regulatory and engineering challenges of combination products. She details the implementation of 21 CFR Part 4, the importance of harmonizing terminology between drug and device sectors, and her work with standards bodies like ASTM and AAMI on TIR 48 and TIR 105. Neadle explains her strategic planning frameworks, including the Merlin Exercise and Design to Value, to navigate complex quality systems and global regulatory differences.

Mentioned

Companies
Johnson & Johnson, Amgen, Unilever, IBM, FDA, Genus
Also
21 CFR Part 4, ASTM, AAMI, TIR 48, TIR 105, ISPE

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 42m

    #323 The Combination Products Handbook

    Susan Neadle, principal consultant and president of Combination Products Consulting Services, discusses her peer-reviewed book, The Combination Products Handbook: A Practical Guide, published by CRC Press. Neadle explains how she collaborated with FDA officials, including John Barwiener, and industry experts from companies like Johnson & Johnson, Novartis, and Pfizer to create a consolidated resource for the complex niche of combination products. The episode details the book's structure, covering regulatory strategies, CGMPs, risk management, and human factors, while highlighting the challenges of harmonizing terminology between pharmaceutical and medical device sectors. Neadle emphasizes the importance of holistic thinking and integrated development to ensure patient safety and regulatory compliance across global jurisdictions.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 50m

    #440: ICYMI (In Case You Missed It!) Fundamentals of Quality & Regulatory

    Jennifer Mascioli-Tudor, CEO of JMT Compliance Consulting and former VP of Quality at Medtronic and Boston Scientific, discusses the evolution of quality and regulatory roles in the medical device industry. She emphasizes that quality professionals must act as strategic influencers and project managers, using storytelling to connect compliance requirements with business outcomes like cost of poor quality. The conversation covers the importance of human factors in design, the nuanced concept of 'design freeze', and the necessity of proactive quality management to ensure patient safety and regulatory agility.

  • Global Medical Device Podcast · 37m

    #390: Building a Non-BS QMS: 4 Core Principles for MedTech Success with Ashkon Rasooli

    Ashkon Rasooli, a quality and regulatory expert, joins host Etienne Nichols to outline four core principles for building an effective, non-burdensome Quality Management System (QMS) for medical device companies. Rasooli argues for 'Quality over Proceduralism,' 'Culture over Mandate,' 'Redundancy over Duplication,' and 'Conciseness over Verbosity' to ensure the QMS serves the business rather than just acting as a compliance checkbox. He advises new founders to engage quality and regulatory advisors early in the design phase to optimize architecture and avoid costly retrospective documentation. The discussion also covers the strategic decision of whether to treat quality as a minimum regulatory hurdle or a key business differentiator.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.